Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Amicus Brain Innovations is a digital health company that leverages artificial intelligence to transform the care experience for individuals living with neurodegenerative diseases and their caregivers. The company's platform provides personalized, evidence-based clinical decision support and guidance to help manage the complexities of Alzheimer's and other forms of dementia. By utilizing advanced machine learning and natural language processing, Amicus Brain offers a digital advisor that assists in navigating care challenges and improving quality of life. Their solutions are designed to bridge the gap between clinical expertise and daily caregiving needs. The company has been recognized with multiple grants from the National Institute on Aging to further develop its innovative AI-driven care solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Amicus Brain Innovations.